The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation
Authors
Keywords
-
Journal
Vaccines
Volume 10, Issue 2, Pages 158
Publisher
MDPI AG
Online
2022-01-24
DOI
10.3390/vaccines10020158
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study
- (2021) Akshay Sharma et al. Lancet Haematology
- Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections
- (2021) Ekaterina Zmievskaya et al. Biomedicines
- Antibody response patterns in COVID‐19 patients with different levels of disease severity in Japan
- (2021) Kazuo Imai et al. JOURNAL OF MEDICAL VIROLOGY
- Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR-T cell therapy
- (2021) Binod Dhakal et al. BLOOD
- Systems vaccinology of the BNT162b2 mRNA vaccine in humans
- (2021) Prabhu S. Arunachalam et al. NATURE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
- (2021) Stephen J. Thomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunological Response Against SARS-COV-2 After BNT162b2 Vaccine Administration Is Impaired in Allogeneic but Not in Autologous Stem Cell Transplant Recipients
- (2021) Martina Chiarucci et al. Frontiers in Oncology
- Humoral Immunity After mRNA SARS-CoV-2 Vaccination in Allogeneic HCT Recipients—Room for Improvement and Much to Learn
- (2021) Joshua A. Hill JAMA Network Open
- Interest of a third dose of BNT162b2 anti‐SARS‐CoV‐2 messenger RNA vaccine after allotransplant
- (2021) Amandine Le Bourgeois et al. BRITISH JOURNAL OF HAEMATOLOGY
- Serological response following BNT162b2 anti‐SARS‐CoV‐2 mRNA vaccination in haematopoietic stem cell transplantation patients
- (2021) Immacolata Attolico et al. BRITISH JOURNAL OF HAEMATOLOGY
- Immunogenicity and safety of the BNT162b2 mRNA COVID‐19 vaccine in haematopoietic stem cell transplantation recipients
- (2021) Noga Shem‐Tov et al. BRITISH JOURNAL OF HAEMATOLOGY
- Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients
- (2021) Lorenzo Canti et al. Journal of Hematology & Oncology
- The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies
- (2021) Chiranjib Chakraborty et al. Frontiers in Pharmacology
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predicted Cellular Immunity Population Coverage Gaps for SARS-CoV-2 Subunit Vaccines and Their Augmentation by Compact Peptide Sets
- (2020) Ge Liu et al. Cell Systems
- Significance of Ethnicity in the Risk of Acute Graft-versus-Host Disease and Leukemia Relapse after Unrelated Donor Hematopoietic Stem Cell Transplantation
- (2013) Yasuo Morishima et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
- (2012) Y Kanda BONE MARROW TRANSPLANTATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now